Clinical trial programme with new c-Met inhibitor for kidney cancer initiated in Australia and New Zealand

By |2018-09-20T07:55:14+00:0020 Sep 2018|Drug treatments|

CBT Pharmaceuticals (a US and China-based biopharmaceutical company) announced the [...]